QA: Abbvie Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2020_Abbvie_Inc.pdf

Logs

Graph

Absolute values for 0001551152, Abbvie Inc

  xvar xval
0 AssetsCurrent 49,519,000,000
1 IntangibleAssetsNetIncludingGoodwill 34,253,000,000
2 PropertyPlantAndEquipmentNet 2,962,000,000
3 remainder_Assets 2,381,000,000
4 LiabilitiesCurrent 15,585,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 7,448,733,775
8 SellingGeneralAndAdministrativeExpense 6,778,376,958
9 ResearchAndDevelopmentExpense 7,882,609,560
10 remainder_Expenses -321,940,080
11 remainder_Revenues 33,347,650,902
12 remainder_NetIncome -1,199,846,286
13 remainder_ComprehensiveNetIncome -604,879,405
  yvar yval
0 Assets 89,115,000,000
1 Liabilities 15,585,000,000
2 Expenses 21,787,780,213
3 Revenues 33,347,650,902
4 StockholdersEquity 73,530,000,000
5 NetIncome 10,360,024,403
6 ComprehensiveNetIncome 10,057,584,700
7 BaseVar 80,820,078,403
8 EconomicCapitalRatiobeforeLimitedLiability 3.25
9 EconomicCapitalRatio 3.86

Edgar->Model Mapping

Feature Distribution

Change over Time